Overview of Сумамед

Property	Description
Active ingredient	Azithromycin dihydrate
Forms	Tablets, Capsules, Powder for Oral Suspension, IV Solution
Pharmacological class	Macrolide Antibiotic (Azalide Subclass)
Common Use	Treatment of Bacterial Infections
Origin	Semi-synthetic (Erythromycin derivative)

What Type of Medicine is Сумамед? (Identity and Classification)

Сумамед is the established trade name for a systemic antibacterial medicinal product whose active ingredient is azithromycin (INN). The medication is formally classified as a macrolide antibiotic, belonging to the distinct azalide subclass. Azithromycin is a semi-synthetic derivative chemically modified from the older macrolide erythromycin. Azithromycin is characterized by enhanced tissue distribution and a prolonged half-life compared to many first-generation macrolides. Azithromycin is included in the World Health Organization’s (WHO) List of Essential Medicines. Its role is clinically recognized for controlling a wide array of bacterial infections.

Composition and Available Forms of Azithromycin (Composition and Form)

The core composition of this prescription-only medicine contains the single active ingredient, typically in the form of azithromycin dihydrate, alongside pharmaceutical excipients. Сумамед, as a brand, is recognized for offering multiple dosage forms, including film-coated tablets, capsules, and a powder for oral suspension particularly useful for pediatric patients. It is also available as a solution for intravenous injection (parenteral administration). The availability of these multiple forms provides comprehensive options for delivering the active substance either orally or directly through the bloodstream, thereby catering to diverse administration needs.

General Principle of Action (Purpose and High-Level Mechanism)

The general purpose of this medicine is to control and relieve the symptoms associated with bacterial infections by directly inhibiting the source of the illness. Azithromycin achieves this by exerting a bacteriostatic effect, meaning it prevents bacteria from growing and multiplying. The drug works by binding to the bacteria's internal machinery—specifically the 50S ribosomal subunit—thereby suppressing the bacterial protein synthesis necessary for their survival and proliferation. This targeted action reduces the bacterial load, which assists the patient's own immune system in clearing the remaining infection.

Regulatory References

Azithromycin Drug Information (NIH/NCBI)

What side effects are possible with Сумамед?

Possible Side Effects and Safety Information

The safety profile of azithromycin (Сумамед) is formally documented by government regulatory agencies, classifying potential adverse reactions by both frequency and the physiological system affected. The most frequently documented adverse effects are generally related to the Gastrointestinal System, setting the baseline for expected reactions.

Adverse reactions are classified into categories such as Very Common (affecting 1 in 10 or more people), which typically includes diarrhea. Common effects (affecting 1 to 10 in 100 people) generally involve nausea, headache, vomiting, and abdominal pain. Effects categorized as Uncommon or Rare include events affecting the Nervous System, Skin, and Hepatobiliary system.

Serious Adverse Reactions and Safety Constraints

The regulatory label specifies several serious adverse reactions that require formal documentation. These include severe Hypersensitivity Reactions (such as Angioedema and Anaphylaxis) and severe cutaneous adverse reactions like Stevens-Johnson Syndrome (SJS). Potential risks to the Cardiac System are also noted, including the risk of QT interval prolongation and the life-threatening ventricular arrhythmia Torsades de Pointes.

High-level safety constraints note that the medication is formally contraindicated in individuals with a known history of hypersensitivity to macrolide antibiotics or a prior history of cholestatic jaundice or liver dysfunction associated with azithromycin. Specific safety considerations are documented for older adults and patients with pre-existing cardiac conditions or severe hepatic impairment, as these populations may face an elevated risk of certain serious adverse events.

Overdose and Emergency Response

Overdose and when to seek help

The following information is based strictly on official regulatory documents describing the manifestations and required actions for overdose.

Overdose Scope

Documented overdose presentations: Overdose primarily manifests as an exaggeration of known adverse effects, including severe gastrointestinal symptoms such as nausea, vomiting, and diarrhea.
Physiological systems affected (as stated in label): The most critical documented effects involve the Cardiovascular system (cardiac repolarization) and the Gastrointestinal system.
Dose-related or exposure-related factors (if applicable): Overdosage results from the intake of higher than recommended doses. Patients with severe renal impairment have been noted to have increased systemic exposure.
Emergency-response statements (as written in official documents): General symptomatic and supportive measures are indicated; there is no specific antidote known.
When immediate medical help is required (label-derived phrasing only): Immediate medical attention must be sought for suspected overdose. Urgent medical care is specifically required for cardiac symptoms like dizziness, fainting, or a fast, pounding, or irregular heartbeat.

Overdose Classifications (high-level)

Severity classification (as defined in official documents): Potential for severe and life-threatening consequences, particularly concerning the risk of Torsades de Pointes (a potentially fatal heart rhythm).
Overdose-context constraints (as defined in official documents): Management requires symptomatic support and continuous cardiac monitoring due to the documented risk of QT prolongation.

Resulting Overdose Structure

Official overdose statements:

Overdosage is associated with the exaggeration of adverse effects, including severe gastrointestinal distress.
The drug carries a documented risk of QT interval prolongation, leading to the potential for the fatal arrhythmia Torsades de Pointes.
No specific antidote is known, and the required response is the application of general symptomatic and supportive measures.

Connection to the overall overdose profile (3 sentences): The regulatory documents formally define the azithromycin overdose profile through the manifestation of amplified gastrointestinal distress alongside the critical, potentially life-threatening risk of cardiac electrical instability. The official guidance mandates that any suspected overdose requires immediate medical help for supportive care and necessary cardiac monitoring. The official description directs that emergency care is the required regulatory action to mitigate the specific severe outcomes documented in the prescribing information.

Therapeutic Uses of Сумамед

What Сумамед Treats: Main Uses and Benefits

The medication is generally applied in clinical settings that involve acute or disruptive symptom patterns, particularly bacterial infections affecting the respiratory system, skin and soft tissues, and genital tract, where it is used as part of supportive management. It is relevant for managing conditions characterized by periods of heightened symptoms like community-acquired pneumonia, acute bronchitis exacerbations, sinusitis, acute otitis media, and uncomplicated skin infections.

Its use may be part of symptomatic management that helps ease symptoms related to physical discomfort like persistent cough, chest congestion, and localized pain, providing support that helps ease the overall symptom burden. It is also relevant for targeted assistance in specialized scenarios, such as managing sexually transmitted infections and Pelvic Inflammatory Disease (PID).

“This approach supports patients during difficult episodes by easing distress in conditions where functional stability becomes affected.”

The medicine is considered relevant for managing conditions involving episodic or fluctuating manifestations in specific contexts, such as MAC. Сумамед is applied when appropriate to help manage symptoms that interfere with daily comfort.

Quick Fact: Relief for Inflammatory Symptoms Relief is generally applied when symptoms create noticeable physiological strain, such as discomfort, swelling, and redness.

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility for Use: Official Regulatory Status

Сумамед (Azithromycin) eligibility is defined by regulatory authorities based on population safety data and documented risk factors. The medicine is generally permitted for use in adults and pediatric patients 6 months of age for most standard indications. Certain indications, such as pharyngitis/tonsillitis, are restricted to children aged two years and older. Safety and effectiveness have not been established for treatment in infants under six months of age.

Contraindications and Restrictions

Use is strictly contraindicated for individuals with a known hypersensitivity to azithromycin, erythromycin, or any macrolide or ketolide antibiotic. It is also prohibited for patients with a documented history of cholestatic jaundice or hepatic dysfunction associated with previous azithromycin use.

Conditional use and caution are required for several populations, including patients with a known QT interval prolongation or other proarrhythmic heart conditions, those with myasthenia gravis (as symptoms may worsen), and patients with severe hepatic impairment or severe renal impairment (GFR < 10 mL/min). Older patients may be more susceptible to cardiac risks. For pregnant and breastfeeding individuals, use is generally recommended only if clearly needed, as determined by official labeling.

What should I know about interactions with other medicines?

Azithromycin, the active component in Sumamed, interacts with a number of other medicinal products, requiring careful management to maintain effectiveness and safety. These interactions are generally categorized by the potential mechanism of effect, such as altered absorption or changes in cardiac activity.

Antacids containing aluminum or magnesium reduce the peak concentration of azithromycin in the bloodstream, which may lower its effectiveness. Therefore, azithromycin should be administered at least two hours before or two hours after these types of antacids.

One of the most significant considerations involves drugs that are known to prolong the QT interval, which relates to the electrical activity of the heart. Concomitant use with azithromycin may increase the risk of serious, sometimes fatal, heart rhythm abnormalities, such as Torsades de Pointes. Patients with pre-existing heart conditions or uncorrected electrolyte imbalances are particularly vulnerable to this risk.

Co-administration with the HIV protease inhibitor Nelfinavir is known to increase the levels of azithromycin in the body, necessitating close monitoring for typical azithromycin side effects, including potential liver and hearing issues. Azithromycin may also increase the effect of oral anticoagulants, like Warfarin, requiring frequent monitoring of the patient's coagulation times.

Mechanism of Action

Direct Inhibition of Bacterial Protein Synthesis

The core function of Azithromycin is to act as a bacteriostatic inhibitor by precisely binding to the 23S rRNA within the bacterial 50S ribosomal subunit. This interaction physically occludes the nascent peptide exit tunnel, preventing the elongation of polypeptide chains and effectively arresting the bacterial cell's ability to create the proteins required for growth and proliferation. The resulting physiological effect is the reduction in the rate of bacterial proliferation through the fundamental suppression of the pathogen's replication machinery.

Targeted Cellular Distribution and Modulation

The drug exhibits a unique mechanism of targeted distribution, achieved through its high accumulation within phagocytic immune cells (macrophages and neutrophils). These cells act as carriers, transporting and concentrating the active substance at sites of increased bacterial activity. This localized accumulation and subsequent slow release contributes to a sustained presence of the inhibitory mechanism in the target tissue, resulting in prolonged physiological exposure to the drug.

Beyond its antimicrobial role, Azithromycin also functions as an immunomodulator. It engages host signaling mechanisms, such as suppressing the activation of the NF-kappaB pathway and reducing the production of specific pro-inflammatory chemokines (e.g., IL-8) by certain immune cells. This secondary mechanism contributes to the attenuation of chemotactic signals and subsequent reduction of immune cell infiltration.

Dosage and Administration Information

Administration Guidelines for Сумамед (Azithromycin)

The use of Сумамед (Azithromycin) follows specific instructions which dictate the correct route, dose, and frequency of administration.

Routes and Schedules

Administration Detail	Instruction Summary
Route of Administration	Oral (tablets, capsules, suspension) and Intravenous (IV) infusion for initial or acute therapy.
Adult Dosing Pattern	Primarily once daily (QD). Typical regimens include a 5-day course (500 mg Day 1, then 250 mg Days 2–5) or a 3-day course (500 mg once daily). Single 1000 mg or 2000 mg doses are utilized for specific conditions.
Pediatric Dosing	Dosing for children weighing less than 45 kg is calculated based on body weight (e.g., 10 mg/kg or 12 mg/kg) using the oral suspension.

Contextual Use and Procedural Steps

Oral tablets may be taken with or without food; however, some specialty oral suspension forms must be taken on an empty stomach (at least 1 hour before or 2 hours after a meal).

For intravenous administration, the lyophilized powder must be reconstituted and then diluted to the proper concentration (1.0 mg/mL or 2.0 mg/mL) and must be delivered as a slow infusion over a period of at least 60 minutes. It must never be administered as a rapid bolus.

In the event of a missed dose, the instruction is to take the dose as soon as it is remembered and take the next dose 24 hours later; do not take two doses at the same time to compensate for the missed one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Сумамед (Azithromycin)

Evidence for Acute Respiratory and Ear Infections

The research base for Azithromycin's use in acute infections of the respiratory system and ear includes Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. Studies have focused on conditions such as Community-Acquired Pneumonia (CAP), Acute Bacterial Sinusitis, and Acute Otitis Media (AOM), and included adults and pediatric patients (children over six months old) in their cohorts. Researchers have explored how symptoms change over time and measured key outcomes related to measures of clinical status and microbiological eradication. The evidence for these acute, specific uses includes High Level research in evidence grading systems, which contributes to understanding symptom patterns.

Evidence for Skin, Soft Tissue, and Genital Tract Infections

Azithromycin was evaluated in RCTs and observational studies for uncomplicated skin and skin structure infections (uSSSI) in adults, and for specific sexually transmitted infections like those caused by Chlamydia trachomatis and Haemophilus ducreyi. Research examined outcomes related to measures of clinical status and measures of microbiological status. For some genital tract infections, a single-dose regimen was studied, with researchers examining microbiological clearance. Studies observed potentially mixed or limited microbiological status when treating non-urogenital infections, meaning certainty remains low.

Evidence for Specialized or Long-Term Conditions

Azithromycin was studied for the long-term management of Acute Bacterial Exacerbations of Chronic Bronchitis (ABECB) in adults and for the treatment and prevention of Mycobacterium avium Complex (MAC). These long-term research scenarios, sometimes spanning a year or more, tracked the frequency of exacerbation events and functional balance. Prolonged use was associated with patterns of bacterial changes over time, and the studies tracked the need for continuous observation.

Research Gaps and Remaining Uncertainties

While many areas are well-characterized by RCTs, certain gaps exist. The follow-up durations were limited in many acute treatment studies, meaning that the long-term effects on recurrence or persistent symptoms are not fully established. The impact on bacterial resistance patterns is an area where continuous observation is required, as resistance is a known factor that can affect performance. Additionally, sample sizes were modest in some specialized studies, meaning the results apply only to the populations studied.

Frequently Asked Questions (FAQ)

Common questions about Сумамед (FAQ)

Q: Why is Сумамед often given for shorter periods than other antibiotics?

Studies and official information indicate that the active ingredient, azithromycin, has a unique mechanism that allows it to accumulate within the body's immune cells and tissue. This targeted distribution and prolonged presence allow it to maintain its effect for several days after the last dose, which supports the typical use of a shorter, concentrated treatment course.

Q: Is it normal to feel tired or dizzy while taking Сумамед?

Official safety documentation notes that effects on the Nervous System, such as feeling tired or dizzy, are documented as potential side effects. These reactions are typically categorized as Uncommon or Rare. The appearance of any new or concerning symptoms is a signal to consult a healthcare provider.

Q: Are there common food or drink interactions with Сумамед?

The official product information addresses interactions with food and certain medications like antacids. While there are no known harmful direct interactions with most common drinks, official guidance notes that alcohol may worsen common side effects like nausea and vomiting and can place additional stress on the body.

Q: How long does Сумамед stay in your system after the last dose?

Azithromycin has a prolonged elimination half-life, meaning it takes a long time for the body to clear the drug. Regulatory pharmacokinetic data indicates its half-life can range from two to four days. This long clearance time allows the drug to maintain an effect in the tissue for several days after the full course is completed.

Q: What is meant by macrolide antibiotics, which includes Сумамед?

Official classification defines Сумамед as a macrolide antibiotic belonging to the azalide subclass. This classification refers to a group of antibiotics that share a specific chemical structure and mechanism of action. These drugs work by inhibiting the bacteria's ability to create the proteins needed for growth.

Q: Is Сумамед ever prescribed as a preventative measure?

Studies and official indications show that azithromycin is sometimes used for long-term management and prevention of certain conditions in specific populations. An example is its use in preventing infections caused by Mycobacterium avium Complex (MAC) in certain patient groups.

Q: Is there any difference in effect between the tablet and suspension forms of Сумамед?

Regulatory documents indicate that Сумамед is available in multiple forms, including film-coated tablets and powder for oral suspension, to suit different administration needs. While the forms may have different instructions regarding taking them with or without food, they deliver the same active ingredient, azithromycin, to the body for the same intended therapeutic effect.

Q: Is there a link between Сумамед and hearing changes?

The potential for hearing issues is mentioned in official safety information, particularly in connection with closely monitoring patients who are taking certain interacting medications. Azithromycin has been linked to temporary changes in hearing (ototoxicity) in rare cases, as documented in regulatory safety materials.

Q: Does Сумамед interact with medications for high blood pressure?

Official product information emphasizes caution when combining azithromycin with any drug known to prolong the QT interval, which is a measure of the heart's electrical activity. Disclosure of all concurrent medications to a healthcare provider is a regulatory requirement for safe use.

Q: Do official documents mention anything about Сумамед affecting mood or sleep?

Official safety documentation notes that effects on the Nervous System are documented as potential side effects, often categorized as Uncommon or Rare. This general category may include disturbances related to mood or sleep. Any persistent or unusual changes in mood or sleep can be reviewed with a healthcare provider.

Q: Is the short course of Сумамед as effective as longer antibiotic courses?

Studies on azithromycin have examined different treatment lengths, including the typical short (3-5 day) courses. Research focuses on measuring clinical status and microbiological eradication to determine the appropriate duration for different infections. The approved short courses are supported by research that tracks clinical status and microbiological clearance for specific indications.

Q: Do you always need to finish the full course of Сумамед, even if you feel better quickly?

Official patient counseling materials describe the need to complete the full prescribed course of treatment. Regulatory guidance states that feeling better early does not mean the infection is fully cleared. The full course is recommended to support complete infection clearance and minimize the potential for developing bacterial resistance.

Q: Can I take pain relievers like ibuprofen or paracetamol while on Сумамед?

General drug interaction databases indicate that most common pain relievers, such as ibuprofen and paracetamol (acetaminophen), do not have a major known direct interaction with azithromycin. However, safety documentation notes that individuals with pre-existing heart, liver, or kidney conditions may require review.

Q: Does Сумамед interact with birth control pills?

Information from drug interaction databases suggests that azithromycin may potentially reduce the effectiveness of some hormonal contraceptives containing ethinyl estradiol. The potential need for additional or alternative contraception, depending on the specific formulation, is a point of discussion for a prescriber.

Q: Does Сумамед affect the effectiveness of vaccines?

Official drug interaction data generally shows no interaction between azithromycin and common inactivated vaccines like the influenza vaccine. However, known interactions exist with certain live bacterial vaccines, such as the oral cholera vaccine, and concurrent use is typically avoided.

Q: Can I drink alcohol while taking Сумамед?

While regulatory sources do not note a harmful direct chemical interaction between azithromycin and alcohol, official guidance notes that some patients choose to avoid alcohol. Consuming alcohol may worsen common drug side effects like nausea and vomiting and can hinder the body’s recovery process from the underlying infection.

Q: Does Сумамед work for dental infections?

Yes, official clinical guidelines support the use of azithromycin for certain bacterial tooth infections (such as dental abscesses). It may be a prescribed option, especially for patients who have known allergies or contraindications to penicillin-type antibiotics.

Q: What is the timeframe for when I should start feeling better after starting Сумамед?

Official pharmacokinetic data indicates that the drug is rapidly absorbed, with maximum concentration in the blood reached in approximately two to three hours. However, the exact timeframe for when a patient will begin feeling symptomatic relief is highly dependent on the type and severity of the specific infection being treated.

Q: Does Сумамед interact with vitamins or supplements?

Current drug interaction reports do not show specific interactions between azithromycin and most common vitamins or non-herbal supplements. However, patients may inform their prescribing healthcare provider of all supplements they take, as a standard safety precaution.

Q: Can Сумамед cause a metallic taste in the mouth?

Yes, changes in taste (known as dysgeusia), which can include a metallic taste or temporary loss of taste, are listed in official safety documentation as potential side effects. These effects are generally temporary and should resolve after the medication is finished.

Q: Can Сумамед cause a yeast infection?

Yes, a yeast infection (candidiasis) is a recognized possible side effect of azithromycin. This is a possibility with many broad-spectrum antibiotics, as they can disrupt the body's natural balance of micro-organisms, allowing yeast to overgrow.

Q: How long does it typically take for side effects of Сумамед to go away?

Most common, mild side effects, such as gastrointestinal upset or fatigue, are temporary and generally begin to resolve within a few hours or days after the last dose. More serious or prolonged effects are documented in the safety profile, and these can be reported to a healthcare provider for review.

Q: Are there specific concerns about Сумамед for people with diabetes?

Official clinical guidelines note that azithromycin is not generally known to cause major direct changes in blood sugar. However, patients with diabetes may monitor their glucose levels while taking any new medication.

Q: What is the recommended period of waiting before taking other antibiotics after finishing Сумамед?

Due to the drug's prolonged presence in the body, a period of several days is necessary to ensure it is fully cleared. Pharmacokinetic studies sometimes use a 'washout' period of up to 21 days in research settings to ensure that the drug's prolonged presence does not interfere with a new treatment. This is due to the drug’s long clearance time.

Q: Can Сумамед be used to treat Traveler's Diarrhea?

Yes, regulatory-supported clinical guidelines recommend azithromycin for the treatment of moderate to severe cases of Traveler's Diarrhea. It is considered an effective option for clearing the bacterial pathogens commonly responsible for this condition.

Q: Why is it noted that Сумамед should not be taken with ergotamine?

Official drug interaction sections warn against this combination because azithromycin can increase the blood levels of ergotamine. This heightened level can lead to excessive narrowing of blood vessels (vasoconstriction), which increases the risk of serious complications involving reduced blood flow to the limbs and vital organs.

Q: What is the purpose of the coating on Сумамед tablets?

The film coating on the tablets is a standard pharmaceutical element designed to serve several key purposes. This coating helps to mask the drug's abnormal taste, making it easier for patients to swallow, and it also contributes to the tablet's physical stability during storage.

How should Сумамед be stored and disposed of?

How to Store and Dispose of Сумамед? (Azithromycin)

Official Storage Conditions

Сумамед (azithromycin) must be stored according to strict regulatory conditions to maintain stability. Tablets, capsules, and the dry powder for suspension must be stored at controlled room temperature, typically 15 C to 30 C (59 F to 86 F), away from excess heat and moisture. The medication must be kept in its original, tightly closed container and strictly out of the reach and sight of children.

Stability and Disposal

The reconstituted liquid suspension has a limited shelf-life; the standard suspension must be discarded after 10 days from mixing. It is mandatory to not freeze the liquid. Unused or expired medication should not be disposed of in wastewater or household trash. The preferred method is using an authorized drug take-back program or following specific governmental household disposal guidelines.

Сумамед